| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |